Nasreen Z Ehtesham Selected Research

Nuclear Respiratory Factor 1

7/2022	Nuclear respiratory factor 1 transcriptomic signatures as prognostic indicators of recurring aggressive mesenchymal glioblastoma and resistance to therapy in White American females.
11/2020	Sensitivity to differential NRF1 gene signatures contributes to breast cancer disparities.
9/2020	Nuclear Respiratory Factor 1 (NRF1) Transcriptional Activity-Driven Gene Signature Association with Severity of Astrocytoma and Poor Prognosis of Glioblastoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nasreen Z Ehtesham Research Topics

Disease

7	Tuberculosis (Tuberculoses) 01/2022 - 01/2008
6	Obesity 01/2020 - 02/2003
5	Neoplasms (Cancer) 07/2022 - 08/2014
5	Infections 01/2022 - 05/2006
5	Type 2 Diabetes Mellitus (MODY) 01/2020 - 02/2003
5	Insulin Resistance 07/2009 - 02/2003
4	Inflammation (Inflammations) 01/2020 - 09/2005
2	Glioblastoma (Glioblastoma Multiforme) 07/2022 - 09/2020
1	Communicable Diseases (Infectious Diseases) 01/2021
1	Reinfection 01/2021
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2021
1	Carcinogenesis 11/2020
1	Breast Neoplasms (Breast Cancer) 11/2020
1	Astrocytoma (Pilocytic Astrocytoma) 09/2020
1	Brain Neoplasms (Brain Tumor) 09/2020
1	Granuloma 01/2018
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2018
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 11/2012
1	Colitis 11/2012
1	Pulmonary Tuberculosis 07/2011
1	Body Weight (Weight, Body) 07/2011
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 09/2009
1	Diabetes Complications 12/2005

Drug/Important Bio-Agent (IBA)

9	ResistinIBA 01/2020 - 02/2003
7	Proteins (Proteins, Gene)FDA Link 01/2022 - 09/2003
3	Nuclear Respiratory Factor 1IBA 07/2022 - 09/2020
3	VaccinesIBA 01/2021 - 01/2008
3	Insulin (Novolin)FDA Link 01/2020 - 09/2003
2	Pharmaceutical PreparationsIBA 01/2022 - 11/2014
2	Transcription Factors (Transcription Factor)IBA 11/2020 - 09/2020
2	Caspase 3 (Caspase-3)IBA 11/2020 - 09/2020
2	Messenger RNA (mRNA)IBA 09/2020 - 07/2005
2	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 11/2012 - 07/2009
2	PPAR gammaIBA 09/2009 - 07/2005
2	Fatty Acids (Saturated Fatty Acids)IBA 07/2009 - 07/2005
2	Cysteine (L-Cysteine)FDA Link 01/2004 - 09/2003
1	MicroRNAs (MicroRNA)IBA 07/2022
1	UbiquitinIBA 01/2022
1	EnzymesIBA 01/2022
1	Ornithine-Oxo-Acid Transaminase (Ornithine Aminotransferase)IBA 01/2022
1	Arginine (L-Arginine)FDA Link 01/2022
1	AerosolsIBA 01/2021
1	MethyltransferasesIBA 01/2021
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2021
1	CarcinogensIBA 01/2021
1	Estrogens (Estrogen)FDA Link 11/2020
1	Phenobarbital (Luminal)FDA Link 11/2020
1	Interleukin-7 (Interleukin 7)IBA 09/2020
1	AntigensIBA 12/2018
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2018
1	glucose-regulated proteinsIBA 01/2018
1	Endoplasmic Reticulum Chaperone BiPIBA 01/2018
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2018
1	Immunologic Factors (Immunomodulators)IBA 01/2017
1	ProteomeIBA 11/2014
1	CarbazolesIBA 08/2014
1	Peroxidase (Myeloperoxidase)IBA 11/2012
1	Dextrans (Dextran)FDA Link 11/2012
1	SodiumIBA 11/2012
1	Alkaline PhosphataseIBA 11/2012
1	alpha-Linolenic Acid (Linolenic Acid)IBA 11/2012
1	Linoleic Acid (Linoleate)IBA 11/2012
1	IronIBA 07/2011
1	C-Reactive ProteinIBA 07/2011
1	Biomarkers (Surrogate Marker)IBA 07/2011
1	Glucose (Dextrose)FDA LinkGeneric 07/2009
1	Peptides (Polypeptides)IBA 11/2008
1	Eukaryotic Initiation Factor-2 (EIF 2)IBA 05/2006
1	alpha-Crystallins (alpha-Crystallin)IBA 12/2005
1	Amino Acids FDA Link 09/2005
1	Trans Fatty AcidsIBA 07/2005
1	Hormones (Hormone)IBA 01/2004

Therapy/Procedure

2	Therapeutics 07/2022 - 12/2017
1	Precision Medicine 01/2021
1	Drug Therapy (Chemotherapy) 01/2021